Analyst
Needham & Company
Equibles does not estimate personal net worth.
Joey Stringer is recorded as Analyst at Needham & Company. Joey Stringer has spoken on 2 investor events across 2 companies, most recently for Phathom Pharmaceuticals, Inc. on April 15, 2026. Those appearances were for Phathom Pharmaceuticals, Inc. (PHAT) and Annexon, Inc. (ANNX). The companies whose calls Joey Stringer spoke on are classified in the Healthcare sector.
“And it's my pleasure to introduce our next presenting company, Fathom Pharmaceuticals. Joining us today from the company is President and CEO Steve Basta and Chief Financial Officer Sanjeev Narula.”
“And it's my pleasure to introduce our next company, Annexon Biosciences. And joining us today from Annexon is President and CEO Doug Love. For those of you joining on the webcast, if you would like to ask a question, you can do so at any time.”
Needham & Company
Analyst
Transcript header (unverified)
ANNX
Biotechnology · Healthcare
